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Abstract
Objective Research suggests that physical activity is
associated with improved breast cancer survival, yet no
studies have examined the association between post-diag-
nosis changes in physical activity and breast cancer out-
comes. The aim of this study was to determine whether
baseline activity and 1-year change in activity are associ-
ated with breast cancer events or mortality.
Methods A total of 2,361 post-treatment breast cancer
survivors (Stage I–III) enrolled in a randomized controlled
trial of dietary change completed physical activity mea-
sures at baseline and one year. Physical activity variables
(total, moderate–vigorous, and adherence to guidelines)
were calculated for each time point. Median follow-up was
7.1 years. Outcomes were invasive breast cancer events
and all-cause mortality.
Results Those who were most active at baseline had a
53% lower mortality risk compared to the least active
women (HR = 0.47; 95% CI: 0.26, 0.84; p = .01).
Adherence to activity guidelines was associated with a
35% lower mortality risk (HR = 0.65, 95% CI: 0.47, 0.91;
p\.01). Neither baseline nor 1-year change in activity
was associated with additional breast cancer events.
Conclusions Higher baseline (post-treatment) physical
activity was associated with improved survival. However,
change in activity over the following year was not asso-
ciated with outcomes. These data suggest that long-term
physical activity levels are important for breast cancer
prognosis.
Keywords Exercise  Recurrence  Survival  Behavior 
Lifestyle
Introduction
Evidence suggests that physical activity may reduce the
risk of developing breast cancer among post-menopausal
women [1–5] and among the most physically active pre-
menopausal women [6]. The Nurses’ Health Study
(n = 2,987) [7] and the Collaborative Women’s Longevity
Study (n = 4,482) [8] found that women who reported at
least 3 metabolic equivalent task (MET) hours per week
had signiﬁcantly lower risk of death from all causes and
from breast cancer. In two smaller cohorts of women
recruited speciﬁcally because of prior early-stage breast
cancer diagnosis, the Health, Eating, Activity, and Life-
style (HEAL) study [9] and the Life After Cancer Epide-
miology (LACE) study [10] (933 and 1,970 women,
respectively), physical activity was shown to have a sig-
niﬁcant protective association with all-cause mortality. In
these two studies, physical activity also tended to be
associated with reduced risk of both recurrence and breast
cancer death, which accounted for the majority of deaths. A
recent report from the Norwegian Counties Study [5]
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post-menopausal breast cancer survivors in the highest
versus lowest category of physical activity participation
(recurrence was not examined). In a Canadian cohort of
1,233 women with incident breast cancer, risks of breast
cancer death and death from all causes were also lower
among the highest versus lowest quartiles of both moderate
and vigorous intensity recreational activity. Additionally,
pre-diagnosis recreational activity, particularly moderate
intensity activity, had a beneﬁcial association with survival
after breast cancer [11].
Little is known about the effect of change in physical
activity level on breast cancer prognosis. While the HEAL
Study [9] analysis revealed a higher mortality risk of
women who decreased their physical activity level from the
year prior to diagnosis to 2 years post-diagnosis, no studies
have examined the potential effect of post-diagnosis
change in physical activity. Proposed mechanisms by
which physical activity (and/or physical activity adoption)
may improve breast cancer survival include reductions in
circulating concentrations of estrogen, insulin and related
growth factors, and inﬂammatory factors [12–14].
The Women’s Healthy Eating and Living (WHEL)
Study was a randomized controlled trial of the effect of a
high-vegetable, fruit, and ﬁber diet on recurrence and
overall survival conducted from 1995 to 2006 among 3,088
women who had completed treatment for Stage I (C1 cm)–
IIIA breast cancer [15]. The low-fat, vegetable-rich WHEL
dietary intervention did not produce signiﬁcant differences
in either breast cancer events (16%) or deaths (10%) from
all causes compared to comparison conditions [16], except
in a subset of women who were not experiencing hot ﬂa-
shes at baseline [17]. We previously reported that while
physical activity alone did not signiﬁcantly predict breast
cancer events or all-cause mortality among the 1,490
WHEL participants assigned to the control group, there
was a cluster effect for physical activity combined with
fruit/vegetable intake. A 50% reduction in mortality risk
was observed among those who were highly physically
active and ate ﬁve or more fruit/vegetable servings per
day, regardless of adiposity [18]. In this report of the full
WHEL cohort, we tested the hypothesis that higher
levels of baseline physical activity alone and 1-year
increases in physical activity would be associated with a
reduction in additional breast cancer events and death
from all causes.
Methods
Details of eligibility criteria, data collection, and breast
cancer outcomes assessment and causes of death have been
reported previously [16] and are brieﬂy summarized here.
Participants
The WHEL trial participants were enrolled at 7 study sites
between 1995 and 2000. Eligibility criteria included diag-
nosis of primary operable invasive stage I (C1 cm), II, or
III and breast carcinoma within the past 4 years; age
18–70 years at the time of diagnosis; no current or planned
chemotherapy; no evidence of recurrent disease or new
breast cancer since completion of initial treatment; and no
other cancer in the past 10 years. Informed written consent
was collected, and the Human Subjects Committee of all
participating institutions approved the study procedures,
and the data are publicly available.
Of the 3,088 WHEL participants, we required partici-
pants to complete physical activity assessments at both
enrollment and at the 12-month time point. Accordingly,
727 of those in the WHEL Study were excluded from this
analysis due to additional breast cancer events \1 year
after randomization (n = 124), death <1 year after ran-
domization (n = 2), loss to follow-up (n = 1), or incom-
plete physical activity data (n = 600). Of the remaining
2,361 women included in these analyses, there were 295
(12.5%) breast cancer events and 163 (6.9%) deaths from
all causes over a median follow-up period of 7.1 years
(range of 1.0 to 10.8 years) from enrollment into the trial.
Data collection
Physical activity was assessed by questionnaire at post-
treatment baseline (at the time of enrollment into the trial)
and at various follow-up points using a 9-item physical
activity measure adapted from the Women’s Health Initia-
tive (WHI) [19]. The physical activity questionnaire asses-
sed frequency, duration, and speed of walking outside the
home and frequency and duration of participation in each of
three intensity levels of exercise: mild, moderate, or stren-
uous (with example activities for each level). As previously
presented[20],activitylevelswereconvertedintometabolic
equivalent task (METs) min per week in accordance with
Ainsworth’s compendium of physical activities [21]: mild
activity was assessed as 3 METs, moderate activity was
assessed as 5 METs, and vigorous activity was assessed as 8
METs. For walking, slow, average, fast, and very fast were
assessed as 2, 3, 4, and 6 METs, respectively. The physical
activitymeasurewas validated againstan accelerometer and
the widely accepted Physical Activity Recall (PAR) among
a subset of 74 WHEL Study participants and was found to
have validity and sensitivity comparable to that of the PAR
[22]. Compared to the accelerometer, the WHI physical
activity measure did not provide a signiﬁcantly different
estimate of physical activity (?6 min or 4%, p = .95).
At both the baseline and 1-year clinic visits, height and
weight were measured using standard protocols and used to
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123calculate body mass index (BMI, kg/m
2). Breast cancer
characteristics (stage, number of positive lymph nodes,
treatment) were veriﬁed using medical record review.
Questionnaires or interviews were used to assess demo-
graphic characteristics (e.g., age, race/ethnicity, and educa-
tion level), reproductive history (menopausal status,
presence/absenceofhotﬂashes),smokingstatus,andalcohol
intake. The Rand SF-36 [23] was used to obtain measures of
self-rated health and pain. Self-rated health was obtained
from the single SF-36 item (‘‘Would you say your health
is…’’ with responses of ‘‘excellent,’’ ‘‘very good,’’ ‘‘fair,’’
and ‘‘poor’’) then categorized as ‘‘poor/fair’’ vs. ‘‘good/very
good/excellent.’’ Pain was assessed usingthe SF-36’s bodily
pain subscale, which consists of two items—one assessing
severity of pain and one assessing the degree to which pain
interfered with daily work (either inside or outside the
home). The reference period for both items was the past
4 weeks, and participants were asked to respond using a
5-pointLikertscale.Thetwoitemscoreswerecombinedand
adjusted for subscale score with a potential range of 0 (worst
possible pain) to 100 (complete freedom from pain).
Assessment of study outcomes
Primary study end points for the WHEL Study were [1]
breast cancer events, deﬁned as the combined outcome of
invasive breast cancer recurrence (local/regional or distal)
or new primary breast cancer and [2] death due to any
cause. Details regarding outcomes assessment have been
published [16]. Brieﬂy, during semi-annual telephone
interviews, clinical staff queried participants about occur-
rence of outcome events, any hospitalization, or new or
current medical diagnoses. Staff then conducted conﬁr-
mation interviews for any report of a breast cancer event or
death for which medical records and death certiﬁcates were
obtained, and data were conﬁrmed at study end for[95%
of participants. Follow-up time was censored at the time of
the participant’s death, at the last documented staff contact
date, or at the study completion date (June 1, 2006).
The breast cancer event-free interval was deﬁned as the
time from date of enrollment (March, 1995–November,
2000) to development of an additional breast cancer event
or study completion. The death-free interval was deﬁned as
the time from enrollment to reported/conﬁrmed death or
study completion.
Statistical analysis
Physical activity
Energy expenditure was calculated separately for mild
activities (MET-level\3.0), moderate activities (MET-
level 3.0–5.9), and vigorous activities (MET-level C 6.0).
A variable was also created for moderate-to-vigorous
physical activity (MET-level C 3.0), which was then used
to create a dichotomous variable (‘‘meeting PA guideline’’)
based on a cutoff of 10.0 MET-h/week, which equates to
150 min/week of moderate-pace walking or the equivalent
amount of other exercise durations/intensities. This cut-
point is consistent with American College for Sports
Medicine’s (ACSM) current aerobic activity recommen-
dation for adults aged C65 or for those aged 50–64 years
who have chronic conditions [24]. The following variables
were created to describe the change in physical activity
from baseline to 1 year: change in adherence to guidelines,
change in total physical activity (MET-h/week), and
change in moderate-to-vigorous physical activity (MET-h/
week). Univariate analyses were used to deﬁne quintiles of
baseline physical activity (both total and moderate–vigor-
ous) and change in total and moderate–vigorous physical
activity from baseline to 1 year.
Covariates
Potential covariates included age categories (\44, 45–54,
55–65, and[65 years), race/ethnicity (non-Hispanic white,
African-American, Hispanic, Asian-American, and other),
education (college graduate: yes, no), fruit/vegetable con-
sumption (\5 servings per day or C5 servings per day,
excluding potatoes and iceberg lettuce), menopausal status
(pre-menopausal, peri-menopausal, and post-menopausal),
smoking status (current, past, and never smokers), alcohol
intake [none, 1–19 g/day (equivalent to \2 drinks/day),
and C20 g/day], hot ﬂashes at baseline (yes, no), and
obesity status as normal weight (\25 kg/m
2), overweight
(25–29.9 kg/m
2), or obese (C30 kg/m
2). Cancer treatment
and tumor characteristics included chemotherapy use (yes,
no), tamoxifen or other anti-estrogen use (yes, no), tumor
type (either or both lobular and ductal invasive, none),
tumor differentiation (well, moderate, poor), and cancer
stage. Given that recruitment occurred from 1995 to 2000,
use of aromatase inhibitors was negligible among WHEL
Study participants and is therefore not included as a
covariate.
Analyses
Cox models were used to determine both unadjusted and
adjusted associations between each of the predictor vari-
ables and each of the two outcomes (additional breast
cancer events, all-cause mortality), and chi-square tests
were conducted to examine the relationship between
physical factors (BMI, cancer characteristics, self-rated
health, bodily pain) and adherence to physical activity
guidelines. Kaplan–Meier plots were use to plot all-cause
mortality stratiﬁed by (a) baseline physical activity and,
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123in a separate plot, (b) change in physical activity from
baseline to 1 year. All tests were two-sided and analyses
were conducted in SAS version 9.1 (Cary, NC).
Results
The cohort for these analyses consisted of 2,361 WHEL
Study participants who were alive and recurrence-free at
1-year follow-up and had completed the 1-year physical
activity questionnaire. Of these, 295 later experienced an
additional breast cancer event and 195 died of any cause.
Baseline characteristics of the total cohort of 2,361
women, stratiﬁed by baseline adherence to physical activity
guidelines, are shown in Table 1. Approximately one-half
of the participants were under 55 years of age, college
graduates, and overweight or obese (BMI C 25.0 kg/m
2).
Almost 90% were non-Hispanic white and 81% were post-
menopausal at baseline.
Baseline physical activity level ranged widely with the
average participant reporting 14.9 (SD = 14.7) MET-h/
week of physical activity. Moderate–vigorous activity
accounted for 80% of total activity. Approximately one-
half of participants were meeting physical activity guide-
lines at baseline and at 1-year follow-up. Participants who
met physical activity guidelines at baseline were slightly
older, leaner, less likely to be post-menopausal, less likely
to smoke cigarettes or to have formerly smoked, and more
likely to be non-Hispanic white and to have a college
degree (p\.05 for all) than those who did not meet the
guidelines. They also had a lower tumor stage at the time
of breast cancer diagnosis, were less likely to have
received chemotherapy, had fewer positive lymph nodes,
and were more likely to use anti-estrogens (p = .05 for
all). Of the 1,175 participants who were meeting the
physical activity guideline at baseline, the vast majority
(n = 962; 82%) were still meeting the guideline at 1 year.
Of the 1,186 women who were not meeting the guideline
at baseline, 899 (76%) were still not meeting the guideline
at 1 year.
Physical activity and additional breast cancer events
Neither baseline physical activity nor baseline-to-1-year
change in physical activity was signiﬁcantly associated
with additional breast cancer events. It was observed that
those in the highest quintile of moderate–vigorous baseline
physical activity had a 33% fewer additional events com-
pared to those in the lowest quintile (p\.05). Given that
the trend across quintiles was not signiﬁcant, this may be
the result of type I error. Alternatively, these observations
may indicate a threshold effect, so that physical activity has
a protective effect on additional breast cancer events only
when the activity is performed at sufﬁcient intensity and in
relatively high amounts.
Of the 1,186 women who were not meeting physical
activity guidelines at baseline, only a very small number
(n = 213; 4.1%) increased physical activity and met
guidelines at 1 year. Unexpectedly, this group was asso-
ciated with higher risk of additional breast cancer events
(p = .04), although as such an increased risk was not
observed when the outcome was mortality, this ﬁnding
might be an artifact.
Physical activity and all-cause mortality
Baseline physical activity was associated with reduced
mortality risk (Table 2). Women who met physical activity
guidelines for aerobic activity at baseline experienced a
35% reduction in risk of mortality relative to those who did
not meet the guideline (see Fig. 1a for Kaplan–Meier
curve). Similarly, those in the highest quintile of total
physical activity (C24.7 MET-h/week, or the equivalent of
at least 60 min of brisk walking, 5 days per week) expe-
rienced a 53% mortality risk reduction relative to those in
the lowest quintile. The association was even more pro-
nounced when physical activity was limited to that of
moderate or vigorous intensity, with those in the most
active quintile at 61% lower risk than those in the least
active category.
Only one signiﬁcant association was observed for
baseline-to-1-year change in physical activity and all-cause
mortality. Those women who were meeting physical
activity guidelines both at baseline and at 1-year follow-up
experienced a 40% reduction in mortality risk (see Fig. 1b
for Kaplan–Meier curve). Those who were meeting phys-
ical activity guidelines at only one time point fared no
better than those who were meeting the guidelines at nei-
ther baseline nor 1-year follow-up.
Sensitivity analyses
The observed association between higher baseline physical
activity and lower all-cause mortality could be an artifact
caused by low-baseline physical activity among women
with latent disease. To address that issue, we re-ran our
adjusted models to the data after excluding 62 women for
whom deaths, additional breast cancer events, or censoring
occurred within 24 months of randomization. This resulted
in a reduced cohort of 2,299 participants, including 122 all-
cause deaths. Results were highly comparable to those in
Table 2 and are therefore not presented.
Based on the previous published ﬁnding that, among
WHEL Study control group participants [18], physical
activity was only associated with improved outcomes
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123Table 1 Baseline characteristics of WHEL participants (N = 2,361) stratiﬁed by adherence to physical activity guidelines
Meeting guidelines Not meeting guidelines p for difference
N Mean (SD) or % N Mean (SD) or %
Age, mean (SD) 1,175 54.3 (9.1) 1,186 53.5 (8.6) .04
Age group (%)
\44 154 13.1% 155 13.1% .02
45–54 434 36.9% 499 42.1%
55–65 411 35.0% 395 33.3%
[65 176 15.0% 137 11.6%
Race/ethnicity
Non-Hispanic White 1,055 89.8% 988 83.3% \.0001
African-American 23 2.0% 47 4.0%
Hispanic-American 40 3.4% 70 5.9%
Asian-American 37 3.2% 45 3.8%
Other 20 1.7% 36 3.0%
College graduate (%) 746 63.5% 562 47.4% \.0001
BMI, mean kg/m
2 (SD) 1,175 25.6 (4.7) 1,186 28.5 (6.6) \.0001
BMI category (%)
\25.0 617 52.5% 422 35.6% \.0001
25–29.9 375 31.9% 361 30.4%
C30.0 183 15.6% 403 34.0%
Menopausal status
Post-menopausal 934 79.5% 970 81.8% \.0001
Pre-menopausal 125 10.6% 107 9.0%
Peri-menopausal 114 9.7% 109 9.2%
Hot ﬂashes (%) 349 29.7% 357 30.1% .98
Time since diagnosis
\2 years 638 54.3% 652 55.0% .74
2–4 years 537 45.7% 534 45.0%
Tumor stage (%)
I 514 43.7% 443 37.4% .003
IIA 378 32.2% 396 33.4%
IIB 121 10.3% 172 14.5%
IIIA 131 11.2% 135 11.4%
IIIC 31 2.6% 40 3.4%
Chemotherapy (%) 759 64.6% 852 71.8% .0008
Radiation (%) 720 61.3% 734 61.9% .95
# positive nodes (%)
0 730 62.1% 671 56.6% .03
1–3 304 25.9% 365 30.8%
[3 141 12.9% 149 12.6%
Anti-estrogen use (%) 836 71.5% 759 65.0% .0007
Smoking status 636 54.1% 663 55.9% .01
Never 508 43.2% 468 39.5%
Former 31 2.6% 55 4.6%
Current
Alcohol (%)
0 339 28.9% 380 32.1% .21
1–19 g/day 786 67.0% 761 64.3%
20? g/day 48 4.1% 42 3.6%
Cancer Causes Control (2011) 22:427–435 431
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intake (C5 servings/day), we tested the full sample (control
and intervention women) for such a relationship. No
interaction was observed; therefore, the presented ﬁndings
include fruit/vegetable consumption as a ﬁrst-order covar-
iate, but not as part of an interaction term.
Table 2 Adjusted analyses for physical activity, change in activity level additional breast cancer events, and death from all causes in a cohort of
women with a history of breast cancer (n = 2,361)
Physical activity (MET-h/week) Nn Additional breast cancer events n All-cause mortality p (trend)
HR (95% CI) pp (trend) HR (95% CI) p
Baseline activity level
Total PA (continuous) 2,361 295 0.99 (0.99, 1.00) .21 163 0.98 (0.96, 0.99) .003
Total PA (categorical)
Quintile 1 [0–2.5] 481 69 Reference .58 43 Reference .08
Quintile 2 (2.5–7.5] 485 65 0.91 (0.64, 1.28) .58 43 1.01 (0.66, 1.55) .97
Quintile 3 (7.5–14.9] 451 53 0.85 (0.59, 1.22) .38 32 0.85 (0.53, 1.35) .48
Quintile 4 (14.9–24.7] 472 60 0.97 (0.68, 1.39) .87 27 0.75 (0.46, 1.23) .26
Quintile 5 (24.7–107] 472 48 0.74 (0.50, 1.10) .13 18 0.47 (0.26, 0.84) .01
Mod-vig PA (continuous) 2,361 295 0.99 (0.98, 1.00) .13 163 0.98 (0.96, 0.99) .002
Mod-vig PA (categorical)
Quintile 1 [0–1.3] 474 70 Reference .30 45 Reference .02
Quintile 2 (1.3–6.3] 473 64 0.97 (0.68, 1.36) .84 38 1.00 (0.64, 1.55) .99
Quintile 3 (6.3–12.5] 474 64 0.98 (0.69, 1.38) .89 41 0.99 (0.64, 1.54) .96
Quintile 4 (12.5–22.9] 470 53 0.91 (0.62, 1.31) .60 24 0.71 (0.42, 1.19) .19
Quintile 5 (22.9–107] 470 44 0.67 (0.45, 1.00) .04 15 0.39 (0.21, 0.72) .003
Meeting PA guideline
a
No 1,186 161 Reference 102 Reference
Yes 1,175 134 0.89 (0.70, 1.14) .36 61 0.65 (0.47, 0.91) .01
Baseline-to-1-year change
Meeting PA guideline
No ? No 899 112 Reference 75 Reference
No ? Yes 287 49 1.44 (1.02, 2.03) .04 27 1.21 (0.77, 1.90) .42
Yes ? No 213 31 1.22 (0.81, 1.83) .34 17 1.04 (0.61, 1.77) .89
Yes ? Yes 962 103 0.93 (0.70, 1.24) .62 44 0.60 (0.40, 0.88) .01
D Total PA (continuous) 2,361 295 1.01 (1.00, 1.02) .26 163 1.00 (0.98, 1.01) .59
D Total PA (categorical)
Quintile 1 [-68.8, -5.5] 474 52 Reference .60 23 Reference .70
Quintile 2 (-5.5, -0.3] 473 58 0.95 (0.64, 1.42) .81 39 1.24 (0.71, 2.16) .45
Quintile 3 (-0.3, 2.3] 474 65 1.24 (0.82, 1.87) .31 40 1.23 (0.69, 2.20) .49
Quintile 4 (2.3, 7.5] 470 57 1.10 (0.73, 1.65) .66 35 1.17 (0.66, 2.09) .60
Quintile 5 (7.5, 92.3] 470 63 1.19 (0.80, 1.77) .39 26 0.89 (0.49, 1.64) .71
D Mod-vig PA (continuous) 2,361 295 1.01 (1.00, 1.02) .23 163 0.99 (0.98, 1.01) .48
D Mod-vig PA (categorical)
b
Quintile 1 [-63.8, -5.3] 476 54 Reference .58 24 Reference .84
Quintile 2 (-5.3, 0] 805 99 0.95 (0.65, 1.40) .76 69 1.17 (1.69, 1.97) .56
Quintile 3 (0, 1.3] 147 18 1.00 (0.57, 1.75) .99 9 0.90 (0.40, 2.02) .81
Quintile 4 (1.3, 7) 563 55 0.99 (0.66, 1.49) .97 32 1.06 (0.60, 1.89) .84
Quintile 5 [7, 92.3] 470 69 1.23 (0.83, 1.80) .30 29 0.92 (0.51, 1.66) .78
All analyses adjusted for age at randomization, race, fruit and vegetable consumption, BMI at randomization, menopausal status, tumor type,
tumor grade, tumor stage, anti-estrogen use, clinical site, time from diagnosis to randomization, hot ﬂashes, and study group
a To approximate guideline of 150 min/wk, we used a cutoff of 10 MET-h/week of moderate-to-vigorous PA
b Quintiles are uneven due to a large number of participants with change scores of exactly 0
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123WHEL Study participants were recruited up to 4 years
after diagnosis. To address the possibility that it was the
physical activity level shortly after diagnosis that mattered,
we conducted a sensitivity analysis using only the 1,071
women who were diagnosed \2 years prior to randomi-
zation. The only result to change was that meeting physical
activity guidelines at baseline was now associated with
reduced breast cancer events (HR = 0.71; 95% CI: 0.51,
0.98; p = .04).
Similarly, removing low-risk women (i.e., Stage I) from
the analysis reduced the sample size to 1,404 breast cancer
survivors. This subgroup analysis did not alter effect sizes,
however, it reduced study power to identify those effect
sizes as signiﬁcant.
Discussion
We found a robust association between level of physical
activity at baseline and breast cancer mortality. We did not
observe a statistically signiﬁcant association between base-
line physical activity and additional breast cancer events,
suggesting that the results for mortality may have been
driven by prognosis after an additional event (including a
possible effect on type of recurrence) rather than a direct
reduction in recurrences or new primaries. Although our
analyses used all-cause rather than breast cancer–speciﬁc
mortality, more than 80% of deaths in the WHEL Study
were due to breast cancer [16]; therefore, the observed
association between higher baseline physical activity and
lower mortality was largely driven by a reduction in breast
cancer–related deaths.
Contrary to expectations, changes in physical activity
from baseline to 1 year were not associated with survival.
It is possible that our 1-year measure of behavior change
did not provide a sufﬁciently long period for the metabolic
and physiologic changes associated with increased or
decreased physical activity to impact cancer outcomes.
Likewise, we observed that the majority of women
who adopted physical activity between enrollment and
a
b
Fig. 1 a All-cause mortality for WHEL Study participants (N = 2,361) stratiﬁed by baseline physical activity level. b All-cause mortality
stratiﬁed by change in physical activity from baseline to 1 year
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123year 1 did not maintain their new activity level over the
long term.
Our ﬁndings with regard to mortality are generally
consistent with previous reports [7, 8]. Similar to the
Nurses’ Health Study, the Collaborative Women’s Lon-
gevity Study, and the Life after Cancer Epidemiology
cohorts, we found that a substantial amount of physical
activity was required to improve breast cancer outcomes.
An exception is the HEAL Study, which observed a beneﬁt
for even very modest levels of physical activity. There are
a number of potential explanations for between-study dif-
ferences in the level of physical activity that is associated
with reduced mortality. The cohorts vary somewhat with
regard to clinical and other participant characteristics.
Perhaps more importantly, the speciﬁc approach to physi-
cal activity measurement and quantiﬁcation also varies. For
example, the Canadian study assessed a wide variety of
physical activity settings (recreational, household, occu-
pational) and categorized results by setting type, whereas
some other studies focused only on recreational or leisure-
time activity and categorized results by intensity (mild,
moderate, vigorous, total). Due to these variations, it is
difﬁcult to directly compare studies with regard to the dose
of physical activity that is necessary to observe a protective
effect on outcomes.
A strength of the WHEL Study was that we assessed
physical activity at two time points, allowing us to assess
the potential effect of changes in physical activity on breast
cancer outcomes. Other strengths included excellent cohort
maintenance (health status conﬁrmed at study end con-
ﬁrmed for [95% of participants) and a multi-site, geo-
graphically diverse sample of breast cancer survivors.
A limitation of the WHEL Study was the use of self-
report of physical activity, which is known to include
random error. However, the study used a standardized
physical activity questionnaire that was validated against
both a physical activity recall procedure and an objective
physical activity measure (7-day accelerometer) within a
subset of WHEL Study participants [22]. The physical
activity questionnaire had good agreement (73%) with the
accelerometer measure and had 100% sensitivity for
meeting the physical activity guideline. Another limitation
is that the WHEL cohort was a fairly racially and ethnically
homogenous sample. Thus, ﬁndings may not apply to
women who are not non-Hispanic White.
Consistent with previous reports, our ﬁndings suggest
that adherence to physical activity guidelines may improve
overall survival among breast cancer survivors. We also
present the ﬁrst examination of post-diagnosis change in
physical activity. We observed a 42% reduction in risk
mortality among those women who were adhering to phys-
icalactivityguidelinesatbothbaselineand1-yearrelativeto
those who did not meet the guideline at either time point.
However, we did not ﬁnd that 1-year change in physical
activity was associated with breast cancer mortality. These
ﬁndings highlight the importance of sustained post-diagno-
sis physical activity and suggest that a 1-year period may be
too short for even relatively large increases in physical
activity to affect breast cancer outcomes. Long-term expo-
sure appears to be the most important determinant of the
relationship between physical activity and breast cancer
mortality. To improve breast cancer outcomes, women
should be encouraged to maintain an active lifestyle over
time, aiming to meet or exceed current physical activity
guidelines. Toward this goal, physical activity promotion
should be incorporated into breast cancer prevention and
control programs. Future studies are needed to further
examine the potential effect of long-term post-diagnosis
change in physical activity on breast cancer outcomes.
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